A detailed history of Cloverfields Capital Group, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Cloverfields Capital Group, LP holds 4,098 shares of LLY stock, worth $3.7 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
4,098
Holding current value
$3.7 Million
% of portfolio
1.14%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$727.2 - $932.06 $2.98 Million - $3.82 Million
4,098 New
4,098 $3.16 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $857B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cloverfields Capital Group, LP Portfolio

Follow Cloverfields Capital Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cloverfields Capital Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cloverfields Capital Group, LP with notifications on news.